MassDevice

InBrain Neuroelectronics completes enrollment in first-in-human BCI trial

InBrain Neuroelectronics announced today that it completed patient recruitment in a first-in-human brain-computer interface ...
Rutland Herald

INBRAIN Neuroelectronics Completes Enrolment of World’s First-in-Human Study of Graphene Neural Interfaces for Brain Decoding & Mapping

INBRAIN Neuroelectronics, a neurotechnology company developing graphene-based brain-computer interface therapeutics (BCI-Tx), ...

Galmed Announces a Collaboration Agreement with Tel Aviv University to Evaluate its SCD1 inhibitor, Aramchol, as a Targeted Therapy for Metastatic Brain Cancers

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver disease and GI oncological therapeutics, announced today a research ...
News Medical

Retrospective study highlights effective management of post-neurosurgery space-occupying cysts

Space-occupying cyst (SOC), a fluid-filled sac that grows in a confined area of the body, is one of the major complications associated with brain tumor resection. Understanding the clinical features ...

Plus Therapeutics Granted U.S. FDA Orphan Drug Designation to REYOBIQ™ in Pediatric Malignant Gliomas

Detailed price information for Plus Therapeutics Inc (PSTV-Q) from The Globe and Mail including charting and trades.
Fred Hutchinson Cancer Center

Protecting what matters most: Proton therapy for brain and central nervous system tumors

Dr. Lisa Ni explains how proton therapy offers more precision when treating brain and central nervous system tumors in ...